Abstract
Obsessive–Compulsive Disorder (OCD) is a chronic, severe disabling neuropsychiatric disorder whose pathophysiology is not yet well defined. Generally, the symptom onset occurs during pre-adult life and affects subjects in different life aspects, including professional and social relationships. Although robust evidence indicates the presence of genetic factors in the etiopathology of OCD, the entirely mechanisms are not totally clarified. Thus, the possible interactions between genes and environmental risk factors mediated by epigenetic mechanisms should be sought. Therefore, we provide a review of genetic and epigenetic mechanisms related to OCD with a deep focus on the regulation of critical genes of the central nervous system seeking possible potential biomarkers.
Similar content being viewed by others
Data availability
Not applicable.
Code availability
Not applicable.
Abbreviations
- 5hmC:
-
5-Hydroxymethylcytosine
- 5mC:
-
5-Methylcytosine
- ADHD:
-
Attention-deficit/hyperactivity disorder
- ASD:
-
Autism spectrum disorder
- BDNF:
-
Brain-derived neurotrophic factor
- CNS:
-
Central nervous system
- CREB:
-
Camp-response element-binding protein
- ESR1:
-
Estrogen receptor 1
- E-WAS:
-
Epigenome-wide association studies
- GABA:
-
Gamma-aminobutyric acid
- G-WAS:
-
Genome-wide association study
- HAMA:
-
Hamilton anxiety rating scale
- HAMD:
-
Hamilton depression rating scale
- LEPR:
-
Leptin receptor gene
- Limk1:
-
Lim domain kinase 1
- LTP:
-
Long-term potentiation
- MAOA:
-
Monoamine oxidase A
- miRNAs:
-
MicroRNAs
- MOG:
-
Oligodendrocyte glycoprotein
- NMDA:
-
N-Methyl-d-aspartate
- NTRK3:
-
Neurotrophin-3 receptor gene
- OCD:
-
Obsessive–compulsive disorder
- OXTR:
-
Oxytocin receptor gene
- RT-qPCR:
-
Reverse transcription quantitative real-time polymerase chain reaction
- SIRT1:
-
Sirtuin
- Y-BOCS:
-
Yale-Brown obsessive–compulsive scale
- YY1:
-
Yin Yang 1
- MDD:
-
Major depressive disorder
References
Anholt G, Aderka I, Van Balkom A, Smit J, Schruers K, Van Der Wee N et al (2014) Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample. Psychol Med 44(1):185
Arora T, Bhowmik M, Khanam R, Vohora D (2013) Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway. Behav Brain Res 247:146–152
Balandeh E, Karimian M, Behjati M, Mohammadi AH (2021) Serum vitamins and homocysteine levels in obsessive-compulsive disorder: a systematic review and meta-analysis. Neuropsychobiology. https://doi.org/10.1159/000514075
Baumgarten HG, Grozdanovic Z (1998) Role of serotonin in obsessive-compulsive disorder. Br J Psychiatry Suppl 35:13–20
Beheshti M, Rabiei N, Taghizadieh M, Eskandari P, Mollazadeh S, Dadgostar E et al (2022) Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy. J Psychiatric Res. https://doi.org/10.1016/j.jpsychires.2022.11.025
Beheshti M, Rabiei N, Taghizadieh M, Eskandari P, Mollazadeh S, Dadgostar E et al (2023) Correlations between single nucleotide polymorphisms in obsessive-compulsive disorder with the clinical features or response to therapy. J Psychiatr Res 157:223–238
Bellia F, Vismara M, Annunzi E, Cifani C, Benatti B, Dell’Osso B et al (2021) Genetic and epigenetic architecture of obsessive-compulsive disorder: in search of possible diagnostic and prognostic biomarkers. J Psychiatric Res. https://doi.org/10.1016/j.jpsychires.2020.10.040
Bellia F, Vismara M, Annunzi E, Cifani C, Benatti B, Dell’Osso B et al (2021) Genetic and epigenetic architecture of obsessive-compulsive disorder: in search of possible diagnostic and prognostic biomarkers. J Psychiatr Res 137:554–571
Bird A (2007) Perceptions of epigenetics. Nature 447(7143):396
Cappi C, Diniz JB, Requena GL, Lourenço T, Lisboa BC, Batistuzzo MC et al (2016a) Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder. BMC Neurosci 17(1):79
Cappi C, Diniz JB, Requena GL, Lourenço T, Lisboa BCG, Batistuzzo MC et al (2016b) Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive–compulsive disorder. BMC Neurosci 17(1):79
D’Addario C, Di Francesco A, Pucci M, Finazzi Agrò A, Maccarrone M (2013) Epigenetic mechanisms and endocannabinoid signalling. FEBS J 280(9):1905–1917
D’Addario C, Bellia F, Benatti B, Grancini B, Vismara M, Pucci M et al (2019) Exploring the role of BDNF DNA methylation and hydroxymethylation in patients with obsessive compulsive disorder. J Psychiatr Res 114:17–23
Edition F (2013) Association AP. Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub. 2013
Feldman R, Monakhov M, Pratt M, Ebstein RP (2016) Oxytocin pathway genes: evolutionary ancient system impacting on human affiliation, sociality, and psychopathology. Biol Psychiat 79(3):174–184
Flavell SW, Greenberg ME (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu Rev Neurosci 31:563–590
Frank DA, Greenberg ME (1994) CREB: a mediator of long-term memory from mollusks to mammals. Cell 79(1):5–8
Gao J, Wang W-Y, Mao Y-W, Gräff J, Guan J-S, Pan L et al (2010) A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466(7310):1105–1109
Goodman SJ, Burton CL, Butcher DT, Siu MT, Lemire M, Chater-Diehl E et al (2020) Obsessive-compulsive disorder and attention-deficit/hyperactivity disorder: distinct associations with DNA methylation and genetic variation. J Neurodev Disord 12(1):1–15
Gottschalk MG, Domschke K, Schiele MA (2020) Epigenetics underlying susceptibility and resilience relating to daily life stress, work stress, and socioeconomic status. Front Psych 11:163
Greally JM (2018) A user’s guide to the ambiguous word’epigenetics’. Nat Rev Mol Cell Biol 19(4):207–208
Grünblatt E, Marinova Z, Roth A, Gardini E, Ball J, Geissler J et al (2018) Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder. J Psychiatr Res 96:209–217
Gürel Ç, Kuşçu GC, Yavaşoğlu A, Biray AÇ (2020) The clues in solving the mystery of major psychosis: The epigenetic basis of schizophrenia and bipolar disorder. Neurosci Biobehav Rev 113:51–61
Hall D, Dhilla A, Charalambous A, Gogos JA, Karayiorgou M (2003) Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Human Genet 73(2):370–376
Hemmings SM, Kinnear CJ, Niehaus DJ, Moolman-Smook JC, Lochner C, Knowles JA et al (2003) Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur Neuropsychopharmacol 13(2):93–98
Hildonen M, Levy AM, Dahl C, Bjerregaard VA, Birk Møller L, Guldberg P et al (2021) Elevated expression of SLC6A4 encoding the serotonin transporter (SERT) in Gilles de la Tourette syndrome. Genes 12(1):86
Huey ED, Zahn R, Krueger F, Moll J, Kapogiannis D, Wassermann EM et al (2008) A psychological and neuroanatomical model of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 20(4):390–408
Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(3):245–254
Jahangard L, Fadaei V, Sajadi A, Haghighi M, Ahmadpanah M, Matinnia N et al (2018) Patients with OCD report lower quality of life after controlling for expert-rated symptoms of depression and anxiety. Psychiatry Res 260:318–323
Jeffery KJ, Reid IC (1997) Modifiable neuronal connections: an overview for psychiatrists. Am J Psychiatry 154(2):156–164
Ji I, Sy W, Numata S, Umehara H, Nishi A, Kinoshita M et al (2016) Association study of polymorphism in the serotonin transporter gene promoter, methylation profiles, and expression in patients with major depressive disorder. Human Psychopharmacol 31(3):193–199
Kandemir H, Erdal ME, Selek S, Ay Öİ, Karababa İF, Ay ME et al (2015a) Microribonucleic acid dysregulations in children and adolescents with obsessive–compulsive disorder. Neuropsychiatr Dis Treat 11:1695
Kandemir H, Erdal ME, Selek S, İzci Ay Ö, Karababa İF, Ay ME et al (2015b) Microribonucleic acid dysregulations in children and adolescents with obsessive-compulsive disorder. Neuropsychiatr Dis Treat 11:1695–1701
Kang H, Schuman EM (1995) Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267(5204):1658–1662
Koo MS, Kim EJ, Roh D, Kim CH (2010) Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder. Expert Rev Neurother 10(2):275–290
Kosaka H, Okamoto Y, Munesue T, Yamasue H, Inohara K, Fujioka T et al (2016) Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: a 24-week randomized clinical trial. Translat Psychiatry 6(8):e872e
Lissemore JI, Leyton M, Gravel P, Sookman D, Nordahl TE, Benkelfat C. OCD: serotonergic mechanisms. PET and SPECT in Psychiatry: Springer; 2014. p. 433–50.
Liu G, Friggeri A, Yang Y, Park Y-J, Tsuruta Y, Abraham E (2009) miR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci 106(37):15819–15824
Liu W, Wu J, Huang J, Zhuo P, Lin Y, Wang L et al (2017) Electroacupuncture regulates hippocampal synaptic plasticity via miR-134-mediated LIMK1 function in rats with ischemic stroke. Neural Plast. https://doi.org/10.1155/2017/9545646
LoParo D, Waldman I (2015) The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis. Mol Psychiatry 20(5):640–646
Mahgoub M, Monteggia LM (2013) Epigenetics and psychiatry. Neurotherapeutics 10:734–741
Martins-Ferreira R, Leal B, Costa PP, Ballestar E (2021) Microglial innate memory and epigenetic reprogramming in neurological disorders. Prog Neurobiol 200:101971
Masini E, Loi E, Vega-Benedetti AF, Carta M, Doneddu G, Fadda R et al (2020) An overview of the main genetic, epigenetic and environmental factors involved in autism spectrum disorder focusing on synaptic activity. Int J Mol Sci 21(21):8290
Mataix-Cols D, Boman M, Monzani B, Rück C, Serlachius E, Långström N et al (2013) Population-based, multigenerational family clustering study of obsessive-compulsive disorder. JAMA Psychiat 70(7):709–717
Mohammadi AH, Balandeh E, Milajerdi A (2021a) Malondialdehyde concentrations in obsessive–compulsive disorder: a systematic review and meta-analysis. Ann Gen Psychiatry 20(1):1–8
Mohammadi AH, Balandeh E, Hasani J, Karimian M, Pourfarzam M, Bahmani F, et al. (2021b) The Oxidative Status and Na+/K+-ATPase Activity in Obsessive-Compulsive Disorder: A Case Control Study. https://doi.org/10.21203/rs.3.rs-1158115/v1
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012
Morgado P, Freitas D, Bessa JM, Sousa N, Cerqueira JJ (2013) Perceived stress in obsessive–compulsive disorder is related with obsessive but not compulsive symptoms. Front Psych 4:21
Muiños-Gimeno M, Guidi M, Kagerbauer B, Martín-Santos R, Navinés R, Alonso P et al (2009a) Allele variants in functional microRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30(7):1062–1071
Muiños-Gimeno M, Guidi M, Kagerbauer B, Martín-Santos R, Navinés R, Alonso P et al (2009b) Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30(7):1062–1071
Nestler EJ (2009) Epigenetic mechanisms in psychiatry. Biol Psychiat 65(3):189–190
Nissen JB, Hansen CS, Starnawska A, Mattheisen M, Børglum AD, Buttenschøn HN et al (2016a) DNA methylation at the neonatal state and at the time of diagnosis: preliminary support for an association with the estrogen receptor 1, gamma-aminobutyric acid B receptor 1, and myelin oligodendrocyte glycoprotein in female adolescent patients with OCD. Front Psych 7:35
Nissen JB, Hansen CS, Starnawska A, Mattheisen M, Børglum AD, Buttenschøn HN et al (2016b) DNA methylation at the neonatal state and at the time of diagnosis: preliminary support for an association with the estrogen receptor 1, gamma-aminobutyric acid B receptor 1, and myelin oligodendrocyte glycoprotein in female adolescent patients with OCD. Front Psych 7:35
Ouellet DL, Perron MP, Gobeil L-A, Plante P, Provost P (2006) MicroRNAs in gene regulation: when the smallest governs it all. J Biomed Biotechnol. https://doi.org/10.1155/JBB/2006/69616
Park S, Lee J-M, Kim J-W, Cho D-Y, Yun H, Han D et al (2015) Associations between serotonin transporter gene (SLC6A4) methylation and clinical characteristics and cortical thickness in children with ADHD. Psychol Med 45(14):3009–3017
Park CI, Kim HW, Jeon S, Kang JI, Kim SJ (2020a) Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder. Clin Epigenetics 12(1):1–8
Park CI, Kim HW, Jeon S, Kang JI, Kim SJ (2020b) Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder. Clin Epigenetics 12(1):101
Pavlova MB, Dyuzhikova NA, Shiryaeva NV, Savenko YN, Vaido AI (2013a) Effect of long-term stress on H3Ser10 histone phosphorylation in neuronal nuclei of the sensorimotor cortex and midbrain reticular formation in rats with different nervous system excitability. Bull Exp Biol Med 155(3):373–375
Pavlova M, Dyuzhikova N, Shiryaeva N, Savenko YN, Vaido A (2013b) Effect of long-term stress on H3Ser10 histone phosphorylation in neuronal nuclei of the sensorimotor cortex and midbrain reticular formation in rats with different nervous system excitability. Bull Exp Biol Med 155(3):373–375
Pittenger C. Obsessive-compulsive disorder: phenomenology, pathophysiology, and treatment: Oxford University Press; 2017.
Pucci M, Di Bonaventura MVM, Wille-Bille A, Fernández MS, Maccarrone M, Pautassi RM et al (2019) Environmental stressors and alcoholism development: focus on molecular targets and their epigenetic regulation. Neurosci Biobehav Rev 106:165–181
Rasmussen SA, Eisen JL, Greenberg BD (2013) Toward a neuroanatomy of obsessive-compulsive disorder revisited. Biol Psychiat 73(4):298–299
Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR et al (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316(5824):608–611
Ruscio AM, Stein DJ, Chiu WT, Kessler RC (2010) The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication. Mol Psychiatry 15(1):53–63
Salta E, De Strooper B (2017) microRNA-132: A key noncoding RNA operating in the cellular phase of Alzheimer’s disease. FASEB J 31(2):424–433
Schiele M, Domschke K (2018) Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. Genes Brain Behav 17(3):e12423
Schiele MA, Gottschalk MG, Domschke K (2020a) The applied implications of epigenetics in anxiety, affective and stress-related disorders-A review and synthesis on psychosocial stress, psychotherapy and prevention. Clin Psychol Rev 77:101830
Schiele MA, Thiel C, Deckert J, Zaudig M, Berberich G, Domschke K (2020b) Monoamine oxidase a hypomethylation in obsessive-compulsive disorder: reversibility by successful psychotherapy? Int J Neuropsychopharmacol 23(5):319–323
Schiele MA, Thiel C, Deckert J, Zaudig M, Berberich G, Domschke K (2020c) Monoamine oxidase a hypomethylation in obsessive-compulsive disorder: reversibility by successful psychotherapy? Int J Neuropsychopharmacol 23(5):319–323
Schiele MA, Thiel C, Kollert L, Fürst L, Putschin L, Kehle R et al (2021) Oxytocin receptor gene DNA methylation: a biomarker of treatment response in obsessive-compulsive disorder? Psychother Psychosom 90(1):57–63
Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M et al (2006) A brain-specific microRNA regulates dendritic spine development. Nature 439(7074):283–289
Sheshachala K, Narayanaswamy JC (2019) Glutamatergic augmentation strategies in obsessive–compulsive disorder. Indian J Psychiatry 61(Suppl 1):S58
Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA et al (2013) Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry 18(7):788–798
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41–45
Taylor S (2011) Etiology of obsessions and compulsions: a meta-analysis and narrative review of twin studies. Clin Psychol Rev 31(8):1361–1372
Teixeira AL, Rodrigues DH, Marques AH, Miguel EC, Fontenelle LF (2014) Searching for the immune basis of obsessive-compulsive disorder. NeuroImmunoModulation 21(2–3):152–158
Wang D, Szyf M, Benkelfat C, Provençal N, Turecki G, Caramaschi D et al (2012) Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS ONE 7(6):e39501
Watanabe T, Otowa T, Abe O, Kuwabara H, Aoki Y, Natsubori T et al (2017) Oxytocin receptor gene variations predict neural and behavioral response to oxytocin in autism. Soc Cognit Affect Neurosci 12(3):496–506
Yue W, Cheng W, Liu Z, Tang Y, Lu T, Zhang D et al (2016a) Genome-wide DNA methylation analysis in obsessive-compulsive disorder patients. Sci Rep 6(1):1–7
Yue W, Cheng W, Liu Z, Tang Y, Lu T, Zhang D et al (2016b) Genome-wide DNA methylation analysis in obsessive-compulsive disorder patients. Sci Rep 6:31333
Yue J, Zhang B, Wang H, Hou X, Chen X, Cheng M et al (2020) Dysregulated plasma levels of miRNA-132 and miRNA-134 in patients with obsessive-compulsive disorder. Annal Translat Med 8(16):996
Acknowledgements
We thank all advisers.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
All authors contributions are equal. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors had no conflict of interest.
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mohammadi, A.H., Karimian, M., Mirzaei, H. et al. Epigenetic modifications and obsessive–compulsive disorder: what do we know?. Brain Struct Funct 228, 1295–1305 (2023). https://doi.org/10.1007/s00429-023-02649-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00429-023-02649-4